Global biopharma non-cold chain product sales 2016-2024
This statistic displays the predicted overall trend for biopharma non-cold chain product sales from 2016 to 2024. In 2020, it is expected that 959 billion U.S. dollars worth of biopharma non-cold chain products will be sold globally. Biopharma products are manufactured or extracted from biological sources; common examples include vaccines, blood and its components, as well as gene therapies.